Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Sill

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Clinical Sarcoma Research|May 10, 2017
Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated casesChristian Koelsche, Daniel Schrimpf, Lars Tharun, et al.
Neuro-Oncology|May 29, 2023
Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter studyAndrew M Donson, Kelsey C Bertrand, Kent A Riemondy, et al.
Acta Neuropathologica|July 11, 2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic gliomaBenedikt Wiestler, David Capper, Martin Sill, et al.
Cell Reports|December 8, 2022
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulationMartin F Orth, Didier Surdez, Tobias Faehling, et al.
Neuro-Oncology|March 14, 2023
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA studyRebecca J Chapman, David R Ghasemi, Felipe Andreiuolo, et al.
Acta Neuropathologica|March 31, 2022
Rapid-CNS<sup>2</sup>: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept studyAreeba Patel, Helin Dogan, Alexander Payne, et al.
Neuro-Oncology|January 31, 2016
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroupsChristian Thomas, Martin Sill, Vincent Ruland, et al.
Nature Communications|November 23, 2024
Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instabilityPetr Smirnov, Moritz J Przybilla, Milena Simovic-Lorenz, et al.
Acta Neuropathologica|May 6, 2017
Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signatureFelix Sahm, Umut H Toprak, Daniel Hübschmann, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Clinical Sarcoma Research|May 10, 2017
Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated casesChristian Koelsche, Daniel Schrimpf, Lars Tharun, et al.
Neuro-Oncology|May 29, 2023
Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter studyAndrew M Donson, Kelsey C Bertrand, Kent A Riemondy, et al.
Acta Neuropathologica|July 11, 2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic gliomaBenedikt Wiestler, David Capper, Martin Sill, et al.
Cell Reports|December 8, 2022
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulationMartin F Orth, Didier Surdez, Tobias Faehling, et al.
Neuro-Oncology|March 14, 2023
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA studyRebecca J Chapman, David R Ghasemi, Felipe Andreiuolo, et al.
Acta Neuropathologica|March 31, 2022
Rapid-CNS<sup>2</sup>: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept studyAreeba Patel, Helin Dogan, Alexander Payne, et al.
Neuro-Oncology|January 31, 2016
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroupsChristian Thomas, Martin Sill, Vincent Ruland, et al.
Nature Communications|November 23, 2024
Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instabilityPetr Smirnov, Moritz J Przybilla, Milena Simovic-Lorenz, et al.
Acta Neuropathologica|May 6, 2017
Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signatureFelix Sahm, Umut H Toprak, Daniel Hübschmann, et al.
Pageof 15